Analyst Price Target is $10.00
▲ +94.93% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Benitec Biopharma in the last 3 months. The average price target is $10.00, with a high forecast of $10.00 and a low forecast of $10.00. The average price target represents a 94.93% upside from the last price of $5.13.
Current Consensus is
Buy
The current consensus among 1 contributing investment analysts is to buy stock in Benitec Biopharma. This Buy consensus rating has held steady for over two years.